Results 51 to 60 of about 54,860 (70)

A Review of the Totality of Evidence in the Development of ABP 798, A Rituximab Biosimilar

Immunotherapy, 2022
Neungseon Seo, Gerd-Rudiger Burmester, Dietger Niederwieser   +2 more
exaly  

Non-clinical similarity of biosimilar ABP 798 with rituximab reference product

Biologicals, 2021
Scott Kuhns, Shea Jassem, Helen Mcbride   +2 more
exaly  

Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product

Biologicals, 2020
Scott Kuhns, Neungseon Seo, Jennifer Liu   +2 more
exaly  

A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis

Clinical Pharmacology in Drug Development, 2020
Gerd-Rudiger Burmester, David Chien
exaly  

Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis

Clinical Rheumatology, 2020
Gerd-Rudiger Burmester, , David Chien
exaly  

Rate and concentration‐dependent effects of UK‐68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration and Vmax

British Journal of Pharmacology, 1991
, David A Lathrop
exaly  

Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay

Journal of Pharmaceutical and Biomedical Analysis, 1991
D K Walker, P E Cross, G W Aherne
exaly  

Interpretation of 798: Changes in Power of Representation and Sustainability of Industrial Landscape

Sustainability, 2015
Juncheng Dai, Zhu Huasheng
exaly  

Validation of five X-chromosomal STRs DXS6800, DXS6807, DXS6798, DXS8377 and DXS7423 in an Antioquian population sample

International Congress Series, 2006
Leonor Gusmão, M L J Bravo, J J Builes   +2 more
exaly  

Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle

Cardiovascular Drugs and Therapy, 1992
David A Lathrop, P M Tande, Helge Refsum   +2 more
exaly